J.W. Cole Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

J.W. Cole Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,093	Closed	-$9.94K	–	829
2023 Q1	$9.94K	Hold	1,093	–	–	﹤0.01%	773
2022 Q4	$12.8K	Hold	1,093	–	–	﹤0.01%	740
2022 Q3	$23K	Sell	1,093 -10	-0.9%	-$270	﹤0.01%	722
2022 Q2	$27K	Sell	1,103 -667	-38%	-$22.7K	﹤0.01%	727
2022 Q1	$88K	Sell	1,770 -667	-27%	-$33K	0.01%	784
2021 Q4	$171K	Buy	2,437 +67	+3%	+$5.64K	0.01%	791
2021 Q3	$221K	Buy	2,370 +27	+1%	+$2.56K	0.02%	423
2021 Q2	$236K	Buy	2,343 +999	+74%	+$97.4K	0.02%	653
2021 Q1	$125K	Sell	1,344 -1,024	-43%	-$104K	0.01%	650
2020 Q4	$195K	Buy	+2,368	New	+$202K	0.02%	598

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

J.W. Cole Advisors's VBIV Position: Q2 2023 in Review

J.W. Cole Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 1,093 shares — an estimated $9.94K sold.

J.W. Cole Advisors first reported a position in VBIV in Q4 2020 and held it in 10 quarters. The position peaked at $236K in Q2 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

J.W. Cole Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
J.W. Cole Advisors sold 1,093 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $9.94K.
J.W. Cole Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2020 and held it in 10 quarters.
J.W. Cole Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $236K in Q2 2021.
46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on J.W. Cole Advisors's 13F filing for Q2 2023, filed 27 Jul 2023.